ROVI announces the agreement with Hikma to distribute and market its Enoxaparin biosimilar


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the...
2 min
13/01/2021